Investors

Vitae Pharmaceuticals is a privately-held company that has raised more than $90 million in capital from top-tier venture firms, strategic corporate investors and a number of individuals. Vitae Pharmaceuticals last venture-led round was in 2004.

Vitae Pharmaceuticals' investors include:

Atlas Venture

Boehringer Ingelheim

GlaxoSmithKline

Intel Capital

New Enterprise Associates

Prospect Venture Partners

Venrock Associates

Wellcome Trust